Clinical Trial Update: Women at Risk of Breast Cancer and OLFM4 [NA]

View source ↗

Summary

An update notes an active-not-recruiting clinical trial investigating OLFM4 in women at risk for breast cancer with Hereditary Breast and Ovarian Cancer Syndrom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Breast and Ovarian Cancer Syndrome

Snippet

Sponsor: Institut Cancerologie de l'Ouest | Conditions: Hereditary Breast and Ovarian Cancer Syndrome | NA | Status: ACTIVE_NOT_RECRUITING